Cldn5 expression is frequently altered in different human cancers, as CLDN5 gene was found to be downregulated in colorectal, liver, and lung cancer and glioma [47,48,49,50], suggestive for a potential tumor-suppressor role of CLDN5 in these cancer types. This evidence concerns the gene CLDN5 and glioma.